T2D: Don’t Sugar Coat It

Join episode host, Todd Eury, founder and CEO of the Pharmacy Podcast Network, as he discusses the indispensable role of pharmacists in T2D care with Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP and Rohit Moghe, PharmD, MSPH, CDCES.

Join experts in T2D: Dr John Anderson (primary care provider), Ms Lucia Novak (Nurse Practitioner), and Dr Joshua Stolker (cardiologist) as they talk about ways to think differently about type 2 diabetes and consider factors in addition to A1C. This podcast is sponsored by Novo Nordisk and is intended for clinicians.

Dr John Anderson, Dr Pam Taub, and Dr Mark Greathouse review the relationship between type 2 diabetes (T2D) and cardiovascular disease (CVD), including how T2D exacerbates CVD and the risk from CVD, and what the national medical associations recommend for patients with T2D and CVD. This podcast is sponsored by Novo Nordisk and is intended for clinicians.

Join experts in T2D: Dr John Anderson, Dr Javier Morales, and Dr Richard Pratley as they review the impact of insufficient GLP-1 activity in patients with T2D. This podcast is sponsored by Novo Nordisk and is intended for clinicians.

Join multidisciplinary experts in T2D: Dr John Anderson, Dr Vivian Fonseca, and Dr Jim Gavin as they discuss the fascinating history of GLP-1 discovery and the role of endogenous GLP-1 in the pathophysiology of T2D. This podcast is sponsored by Novo Nordisk and is intended for Healthcare Practitioners.

Join primary care experts in T2D: Dr. John Anderson, Dr. Stephen Brunton and Dr. James LaSalle as we discuss the beta-cell function and its critical role in T2D pathogenesis.

Join experts in T2D: Dr. John Anderson, Dr. Susan Cornell, and Dr. Doron Schneider as they discuss the enormous physical, emotional, psychological, and economic burden of T2D and its comorbidities on the US healthcare system and their patients.

Join experts in T2D: Dr. John Anderson, Dr. Eden Miller, and Dr. Serge Jabbour for an in-depth discussion on how COVID-19 impacts patients with T2D and what you can do to help your patients as new information is discovered.